Patients should understand that blood pressure changes may occur but that they should never independently discontinue prescribed antihypertensive medications
Contact your doctor promptly if you notice any symptoms of dehydration, such as unusual dry mouth/thirst, fast heartbeat, or dizziness/lightheadedness
Potential candidates People with documented L-carnitine deficiency (rare but does occur, particularly in individuals with certain genetic conditions, kidney disease, or those on dialysis) have a clear medical rationale for L-carnitine supplementation

Mechanisms hypothesised to underlie blood pressure reduction with tirzepatide include: Weight reduction : Loss of adipose tissue decreases sympathetic nervous system activity, reduces cardiac output, and improves insulin sensitivityall contributing to lower blood pressure Natriuresis : GLP-1 receptor activation may promote sodium excretion through renal effects, though direct evidence for tirzepatide is limited [10] Improved endothelial function : Weight loss and metabolic improvements may enhance vascular health Reduced inflammation : Adipose tissue reduction decreases pro-inflammatory cytokines that may contribute to hypertension It is important to note that whilst the blood pressure reductions are consistent across trials, tirzepatide is not licensed as an antihypertensive agent
These in vitro findings were confirmed by a recent study focused on 25 CKD patients
it sets realistic expectations about how long changes take